ICoP SpA SB shares rose 3.0% to €27.7 in todays session after Equita upgraded the stock from "hold" to "buy" following the Italian construction firm's preliminary first-half results that came in above the brokers expectations.
Results and broker response
Equita emphasised that ICoPs first-half core profit margin exceeded its forecast, reported above 18% compared with its estimate of 17%. The broker also noted a backlog of c1.5 billion, which it described as stable relative to full-year 2025. Management confirmed guidance for 2026 and reiterated the targets outlined in the company's plan through 2029.
In light of the stronger margin and the revenue mix leaning toward foundations and microtunneling, Equita raised its 2026 revenue and EBITDA estimates for ICoP and made modest upward adjustments to its projections through 2029. The broker increased its standalone price target by 7.5% to c37 per share.
Separately, Equita argued that a potential takeover of Trevi would generate additional value, estimating that combining the two companies could add a further 13.5% in value creation and implying a price target of c42 per share for the combined entity.
Market context and price action
Broad market moves offered little directional impetus to the equity today. U.S. benchmarks were essentially flat, with the S&P 500 edging down 0.02% while the Nasdaq was up 0.02%. There were no identifiable European Central Bank announcements or major Italian domestic macro data releases that materially shifted sentiment in the domestic market.
Given the lack of a clear macro catalyst, the share move appears to reflect thin-volume dynamics in a small-cap stock supported by a positive analyst view rather than a single identifiable event. ICoP remains roughly 15% below its 52-week high of c32.5 and has more than doubled since its 52-week low of c15.5. That price range appears to be drawing incremental buying from investors who see the pullback from the June peak as an entry opportunity.
Takeaways
- Equitas upgrade followed preliminary H1 results that topped the brokers estimates on margin and supported higher near-term forecasts.
- Company guidance for 2026 and targets through 2029 were reconfirmed, providing continuity to the strategic outlook communicated by management.
- Price appreciation today likely reflects a mix of analyst optimism and low trading volume in a small-cap name rather than broad market direction.